The emergence of diabetes as a major and increasing public health problem in both developed and developing countries of the world has resulted in a considerable growth in activities relating to the World Health Organization (WHO) programme for diabetes in recent years.
As compared with the six proposed or designated WHO collaborating centres in the field of diabetes identified in 1984, by 1987 this number had grown to 26. Currently, approximately one-quarter of all WHO collaborating centres associated with the WHO Division of Noncommunicable Diseases (which includes programmes for cancer, cardiovascular diseases, occupational health, oral health, rheumatic diseases and the Integrated Programme for Community Health in Noncommunicable Diseases are designated for diabetes mellitus.
This rather remarkable international development generated a growing feeling that it would be valuable for the centres to meet on suitable occasions. This could foster understanding and promote cooperative activities aimed at supporting the WHO diabetes programme. With this in mind; an informal gathering of heads of existing collaborating centres took place in conjunction with the 12th Congress of the International Diabetes Federation in Madrid, Spain in September 1985. Thanks to the generous support of the Kentucky Diabetes Foundation, the heads of the WHO collaborating centres in the field of diabetes were able to meet formally for the first time in Lexington, Ky, USA in June 1987. A number of pertinent issues emerged from the meeting.
The history of the WHO activities relating to diabetes were reviewed, including the Expert Committee meetings of 1965 and 1979, and the Study Group meeting of 1985 (the latter two under the chairmanship of Professor H. Keen). These meetings had each resulted in the publication of important technical documents by WHO [1] [2] [3] which had proved to represent milestones in the diagnosis, classification and research directions for diabetes.
The 30th anniversary of the association between WHO and the International Diabetes Federation (IDF, which in 1957 became only the second non-governmental organization to develop official relations with WHO) was also acknowledged.
It was recognised that resources for diabetes within the regular budget of WHO were extremely limited. This gave strength to the argument that the network of collaborating centres, with their much greater collective resources, could fulfill a key role in advancing the cause of diabetes internationally. Very lively interest in this concept was expressed by all of those present at the meeting, and much discussion centered the mechanisms, whereby this might be conveniently effected.
The meeting considered the long awaited WHO Action Programme for Diabetes [4] as a natural framework for their activities, and advocated attention to the further development of this concept.
There was also general agreement that a more defined structure for the collaborating centres could assist in their mutual efforts.
The Lexington meeting also convened expert panel sessions which considered the fields of epidemiology, prevention and care, education, clinical research and technology. Each panel produced a series of recommendations and agreed to cooperate together to advance their individual fields. The meeting concluded with the nomination of an informal interim steering group under the chairmanship of Dr. D. Etzwiler, and with warm expressions of gratitude to Dr. S. Leichter, his collcagues and assistants, and the Kentucky Diabetes Foundation for making this historic meeting such a success.
Coinciding with the 13th Congress of the International Diabetes Federation in Sydney, Australia in November 1988, those heads of WHO collaborating centres in the field of diabetes who werc attending the congress took the opportunity to meet again on an informal basis to discuss developments which had taken place since the meeting in Lexington. Under the chairmanship of Dr. Etzwiler, the meeting was honoured and greatly assisted by the participation of two senior representatives of WHO, Dr. Hu Ching-Li, Assistant Director-General and Dr. E. Chigan, Director of the Division of Noncommunicable Diseases.
Dr. Hu gave the meeting the benefit of his considerable experience and insight into the mechanisms by which WHO could interact with its collaborating centres. He also explained that at present, diabetes represented only a component of a single programme within the Division of Noncommunicable Diseases. Although the growing worldwide importance of diabetes was fully recognised by WHO, a number of practical and financial constraints, as well as the competing needs of other disease-oriented programmes, made it very difficult for WHO to extend greater resources to diabetes activities at the present time. The goal of greater permanent staff support for diabetes within the Division of Noncommunicable Diseases had been accepted long ago. The heads of WHO collaborating centres in the field of diabetes, as well as the regional representatives of the IDF, had an important role to play in bringing the diabetes situation to the attention of their representatives at the world Health Assembly.
Dr. H. King, the Medical Officer for diabetes at WHO Headquarters, reviewed some of the recent and future activities of the WHO diabetes programme. These included the three successful seminars on the epidemiology and public health aspects of diabetes held in Cambridge, United Kingdom, the development of a technical manual for diabetes surveys publication of statistical information on diabetes worldwide [5, 6] 
